Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).

NCT02202538 is registered in ClinicalTrials.gov with Parker Hannifin Corporation as lead sponsor.

NCT NCT02202538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02202538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).
Lead sponsor
Parker Hannifin Corporation
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2014
Completion date
October 31, 2015
Enrollment
53 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury